EVOK: Evoke Pharma Inc. Stocks News on August 18, 2025

EVOK

Simply Wall St.

2 months ago

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK)

EVOK

GlobeNewswire

3 months ago

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update

EVOK

GlobeNewswire

4 months ago

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025

EVOK

Simply Wall St.

5 months ago

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates

EVOK

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Evoke Pharma Inc Earnings Call

EVOK

GuruFocus.com

5 months ago

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans

EVOK

GlobeNewswire

5 months ago

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

EVOK

GlobeNewswire

5 months ago

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025

EVOK

GlobeNewswire

6 months ago

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

EVOK

Insider Monkey

7 months ago

Here’s Why Evoke Pharma, Inc. (NASDAQ:EVOK) Is Among the Best Diabetes Stocks to Buy Under $10

EVOK

GlobeNewswire

8 months ago

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends

EVOK

GlobeNewswire

8 months ago

Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®

EVOK

Simply Wall St.

9 months ago

Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations

EVOK

GlobeNewswire

9 months ago

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results

EVOK

Simply Wall St.

9 months ago

Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit

EVOK

GuruFocus.com

10 months ago

Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis

EVOK

MT Newswires

10 months ago

Evoke Pharma Says Study Showed Gimoti Reduces Emergency Visits in Diabetic Gastroparesis Patients Using GLP-1; Shares Surge Pre-Bell

EVOK

MT Newswires

10 months ago

Top Premarket Gainers

EVOK

GlobeNewswire

10 months ago

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®

EVOK

GlobeNewswire

10 months ago

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting

EVOK

GlobeNewswire

10 months ago

Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors

EVOK

GlobeNewswire

a year ago

Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion

EVOK

GuruFocus.com

a year ago

Nantahala Capital Management's Recent Transaction in Evoke Pharma Inc

EVOK

GlobeNewswire

a year ago

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

EVOK

GlobeNewswire

a year ago

Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference

EVOK

GlobeNewswire

a year ago

Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference

EVOK

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Late Afternoon

EVOK

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

EVOK

MT Newswires

a year ago

Evoke Pharma Shares Rise After Regaining Nasdaq Compliance

EVOK

Simply Wall St.

a year ago

Evoke Pharma Second Quarter 2024 Earnings: Misses Expectations

EVOK

GlobeNewswire

a year ago

Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results

EVOK

GlobeNewswire

a year ago

Evoke Pharma, Inc. Supports Gastroparesis Awareness Month

EVOK

GlobeNewswire

a year ago

Evoke Pharma, Inc. Announces Reverse Stock Split

EVOK

GlobeNewswire

a year ago

Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI

EVOK

GlobeNewswire

a year ago

Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference

EVOK

GlobeNewswire

a year ago

Evoke Pharma Reports First Quarter 2024 Financial Results

EVOK

GlobeNewswire

a year ago

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications

EVOK

GlobeNewswire

a year ago

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer

EVOK

Simply Wall St.

a year ago

Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?

EVOK

Insider Monkey

a year ago

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript

EVOK

Thomson Reuters StreetEvents

a year ago

Q4 2023 Evoke Pharma Inc Earnings Call

EVOK

GlobeNewswire

a year ago

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

EVOK

GlobeNewswire

a year ago

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024

EVOK

GlobeNewswire

2 years ago

Evoke Pharma Announces Closing of $7.5 Million Public Offering

EVOK

GlobeNewswire

2 years ago

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million

EpicQuest Education Announces Bold Strategy as it Hosts the World Cup Argentina Soccer Team Led by Lionel Messi for a Major Revenue Boost

EVOK

PR Newswire

2 years ago

EpicQuest Education Announces Bold Strategy as it Hosts the World Cup Argentina Soccer Team Led by Lionel Messi for a Major Revenue Boost

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

EVOK

GlobeNewswire

2 years ago

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

EVOK

GlobeNewswire

2 years ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

FibroGen, Inc. (NASDAQ:FGEN) institutional owners may be pleased with recent gains after 96% loss over the past year

EVOK

Simply Wall St.

2 years ago

FibroGen, Inc. (NASDAQ:FGEN) institutional owners may be pleased with recent gains after 96% loss over the past year

Regis to Issue Second Quarter Fiscal 2024 Results on January 31, 2024

EVOK

Business Wire

2 years ago

Regis to Issue Second Quarter Fiscal 2024 Results on January 31, 2024

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

EVOK

GlobeNewswire

2 years ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

EVOK

Business Wire

2 years ago

Oragenics Announces Termination of At-The-Market Offering Program

Western New England Bancorp (WNEB) Lags Q4 Earnings Estimates

EVOK

Zacks

2 years ago

Western New England Bancorp (WNEB) Lags Q4 Earnings Estimates

EVOK

Associated Press Finance

2 years ago

Western New England Bancorp: Q4 Earnings Snapshot

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

EVOK

GlobeNewswire

2 years ago

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

Golden Minerals Begins Mining Operations at Velardeña Silver-Gold Properties

EVOK

Business Wire

2 years ago

Golden Minerals Begins Mining Operations at Velardeña Silver-Gold Properties

SurgePays Announces Closing of $15 Million Public Offering

EVOK

GlobeNewswire

2 years ago

SurgePays Announces Closing of $15 Million Public Offering

Score a Free Haircut with Supercuts High Score Promotion

EVOK

PR Newswire

2 years ago

Score a Free Haircut with Supercuts High Score Promotion

Lightbridge Announces Upcoming Industry Event and Media Interview

EVOK

GlobeNewswire

2 years ago

Lightbridge Announces Upcoming Industry Event and Media Interview

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

EVOK

NewMediaWire

2 years ago

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend

EVOK

GlobeNewswire

2 years ago

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend

LM Funding Invests in S21 Bitmain Mining Machines in Advance of 2024 Bitcoin Halving Event

EVOK

GlobeNewswire

2 years ago

LM Funding Invests in S21 Bitmain Mining Machines in Advance of 2024 Bitcoin Halving Event

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

EVOK

Zacks

2 years ago

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

EVOK

Motley Fool

2 years ago

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

Spectaire Launches into European Trucking Market with Signed Distribution Agreement

EVOK

CNW Group

2 years ago

Spectaire Launches into European Trucking Market with Signed Distribution Agreement

$Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients$

EVOK

GlobeNewswire

2 years ago

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications

EVOK

GlobeNewswire

2 years ago

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

EVOK

Simply Wall St.

2 years ago

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

EVOK

Business Wire

2 years ago

Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance

EVOK

Business Wire

2 years ago

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance

JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

EVOK

PR Newswire

2 years ago

JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami

EVOK

PR Newswire

2 years ago

Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami

Chenghe Acquisition I Co. Receives Nasdaq Notice Regarding Late Form 10-Q Filings

EVOK

PR Newswire

2 years ago

Chenghe Acquisition I Co. Receives Nasdaq Notice Regarding Late Form 10-Q Filings

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

EVOK

Simply Wall St.

2 years ago

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

Best Momentum Stocks to Buy for December 19th

EVOK

Zacks

2 years ago

Best Momentum Stocks to Buy for December 19th

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

EVOK

GlobeNewswire

2 years ago

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

EVOK

Reuters

2 years ago

Chinese wealth manager Hywin to offer resolution plans after missed payments

Is Crexendo, Inc. (NASDAQ:CXDO) Trading At A 48% Discount?

EVOK

Simply Wall St.

2 years ago

Is Crexendo, Inc. (NASDAQ:CXDO) Trading At A 48% Discount?

AG Mortgage Investment Trust, Inc. Announces Fourth Quarter 2023 Common Dividend

EVOK

Business Wire

2 years ago

AG Mortgage Investment Trust, Inc. Announces Fourth Quarter 2023 Common Dividend

EVOK

PR Newswire

2 years ago

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS

Aesthetic Medical International Announces Change of Auditor and Change of Director

EVOK

GlobeNewswire

2 years ago

Aesthetic Medical International Announces Change of Auditor and Change of Director

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

EVOK

ACCESSWIRE

2 years ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

ChoiceOne Financial Services, Inc. (NASDAQ:COFS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

EVOK

Simply Wall St.

2 years ago

ChoiceOne Financial Services, Inc. (NASDAQ:COFS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

EVOK

GlobeNewswire

2 years ago

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

EVOK

GlobeNewswire

2 years ago

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

IBN Coverage Initiated for Turbo Energy S.A.

EVOK

GlobeNewswire

2 years ago

IBN Coverage Initiated for Turbo Energy S.A.

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

EVOK

PR Newswire

2 years ago

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

EVOK

PR Newswire

2 years ago

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

EVOK

Business Wire

2 years ago

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

Trevena Awarded OLINVYK Agreement with Premier, Inc.

EVOK

GlobeNewswire

2 years ago

Trevena Awarded OLINVYK Agreement with Premier, Inc.

EVOK

PR Newswire

2 years ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

EVOK

News Direct

2 years ago

Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray

Senstar Technologies Reports Third Quarter 2023 Financial Results

EVOK

PR Newswire

2 years ago

Senstar Technologies Reports Third Quarter 2023 Financial Results

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

EVOK

GlobeNewswire

2 years ago

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

CPS Technologies Corporation to Participate in Virtual Investor Summit on December 7, 2023

EVOK

GlobeNewswire

2 years ago

CPS Technologies Corporation to Participate in Virtual Investor Summit on December 7, 2023

Here's Why We Think Art's-Way Manufacturing (NASDAQ:ARTW) Is Well Worth Watching

EVOK

Simply Wall St.

2 years ago

Here's Why We Think Art's-Way Manufacturing (NASDAQ:ARTW) Is Well Worth Watching

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

EVOK

GlobeNewswire

2 years ago

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

EVOK

GlobeNewswire

2 years ago

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

EVOK

ACCESSWIRE

2 years ago

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

EVOK

PR Newswire

2 years ago

Latest Evoke Pharma Inc. (EVOK) News on August 18, 2025

Share on Social Networks: